The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery

Obesity Surgery

Volumn 15, Issue 9, 2005, Pages 1309-1314

  Ziolkowski, Adam ^a   Wylezol, Mariusz ^a   Kukla, Michal ^a   Zwirska Korczala, Krystyna ^a   Berdowska, Agnieszka ^a   Pardela, Marian ^a   Gabriel, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bariatric surgery; Hepatic steatosis; Inflammatory activity; Liver fibrosis; Morbid obesity; Scoring system

Indexed keywords

ADULT; ARTICLE; BARIATRIC SURGERY; BRUNT SCALE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIXON SCALE; EVALUATION; FATTY LIVER; HEPATITIS; HISTOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; MATTEONI CLASSIFICATION; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; PORTAL VEIN; PRIORITY JOURNAL; RATING SCALE; SCHEUER SCALE; SCORING SYSTEM;

ADULT; BILIOPANCREATIC DIVERSION; BIOPSY; FATTY LIVER; HUMANS; LIVER; MIDDLE AGED; OBESITY, MORBID;

EID: 27644599029     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089205774512582     Document Type: Article

References (25)

1. Dixon JB, Bhathal PS, Hughes NR et al. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology 2004; 396: 1647-54.
2. Kohan M, López D, Botto G et al. Steatohepatic cirrhosis in a morbidly obese patient. Acta Gastroenter Latinoam 1999; 29: 271-5.
3. Gastrointestinal surgery for severe obesity. National Institutes of Health Consensus Conference Development Conference Draft Statement. Obes Surg 1991; 1: 257-66.
4. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg 2004; 14: 1157-64.
5. Baltasar A, Serra C, Pérez N et al. Clinical hepatic impairment after the duodenal switch. Obes Surg 2004; 13: 77-83.
6. Castillo J, Fabrega E, Escalante CF et al. Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbidly obesity. Obes Surg 2001; 11: 640-2.
7. Grimm IS, Schindler W, Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am J Gastroenterol 1992; 87: 775-9.
8. Langdon DE, Leffingwell T, Rank D. Hepatic failure after biliopancreatic diversion. Am J Gastroenterol 1993; 88: 321.
9. Moretto M, Kupski C, Mottin CC et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg 2003; 13: 622-4.
10. Wolf AM, Busch B, Kuhlmann HW et al. Histological changes in liver of morbidly obese patients: correlation with metabolic parameters. Obes Surg 2005; 15: 228-37.
11. Spaulding L, Trainer Th, Janiec D. Prevalence on nonalcoholic steatohepatitis in morbidly obese subjects undergoing gastric bypass. Obes Surg 2003; 13: 347-9.
12. Neuschwander-Terti BA, Caldwell SH. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-19.
13. Brunt EM, Janney CG, Di Bisceglie AM et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 2000; 95: 1370-1.
14. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
15. Matteoni CA, Younossi ZM, Gramlich T et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-19.
16. Marceau P, Biron S, Hould FS et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-7.
17. Beymer C, Kowdley KV, Larson A et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg 2003; 138: 1240-4.
18. Gabriel A, Ziólkowski A. Proposition of histopathologic examination protocol of liver specimen in diagnosing chronic hepatitis. Pol Merk Lek 1997; 2: 320-3.
19. Ratziu V, Bonyhay I, Di-Martino V et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002; 35: 1485-93.
20. Charlton M, Kasparova P, Weston S et al. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease. Liver Transplant 2001; 7: 608-14.
21. Shalhub S, Parsee A, Gallagher SF et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg 2004; 14: 54-9.
22. Papadia FS, Marinari GM, Camerini G et al. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. Obes Surg 2004; 14: 952-8.
23. Bahrami H, Daryani NE, Mirmomen S et al. Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients. BMC-Gastroenterol 2003; 3: 27-33.
24. Del Gaudio A, Boschi L, Del Gaudio GA et al. Liver damage in obese patients. Obes Surg 2004; 12: 802-4.
25. International Working Party. Terminology of chronic hepatitis. Am J Gastroenterol 1995; 90: 181-9.